Cytovia Therapeutics Brings Cancer Treatment R&D to Massachusetts
Cytovia Therapeutics, Inc. has announced the expansion of their R&D labs into Natick, MA. They are hoping the combination of advanced lab space, cost-effective cGMP manufacturing capabilities, and local talent will help to rapidly increase their research. “We’re excited to rapidly expand our R&D team with the best talent in the Boston area.” said Wei Li, Chief Scientific Officer of Cytovia Therapeutics.
Cytovia is a biopharmaceutical company aiming to accelerate patient access to transformational immunotherapies. Their Massachusetts research will focus primarily on their off-the-shelf gene-edited Chimeric Antigen Receptor (CAR) – NK cells. This could accelerate their research into clinical trials by the end of 2021. The Natick Laboratories will comprise four key activities:
- NK cell biology
- Gene-editing
- Antibody and CAR development
- NK cell pilot manufacturing
The new laboratories offer streamlined control over cGMP production by providing a facility designed to meet all scale and regulatory requirements outlined by the FDA, EMA, and global regulatory audits. They can also expect to successfully implement multi-product manufacturing processes which will position the company to produce their therapeutics at large scales.
Are you redesigning existing technology? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
